Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

OLMA US Equity

Olema Pharmaceuticals, Inc.Health Care · Pharmaceutical Preparations · CIK 1750284 · FY ends Dec 31
$11.31
+0.66 (+6.20%)
USD · as of 2026-08-19 · marketstack
16 8-K filings · 0 13D · 11 13G
DateEventWhat happened / filerSource
2026-08-138-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-138-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-08-108-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-0613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-07-2913G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-06-238-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-268-K 8.01Other eventssec.gov ↗
2026-05-268-K 7.01Regulation FD disclosuresec.gov ↗
2026-05-218-K 8.01Other eventssec.gov ↗
2026-05-218-K 7.01Regulation FD disclosuresec.gov ↗
2026-05-1513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Bain Capital Life Sciences Opportunities IV, L.P.sec.gov ↗
2026-05-1513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by JANUS HENDERSON GROUP PLCsec.gov ↗
2026-05-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-05-018-K 2.03Creation of a direct financial obligationsec.gov ↗
2026-05-018-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-04-298-K 7.01Regulation FD disclosuresec.gov ↗
2026-04-298-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-03-2013GSchedule 13G filed — ≥5% beneficial owner (passive) · by Invus Global Management, LLCsec.gov ↗
2026-03-168-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-03-0613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-02-1713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by JANUS HENDERSON GROUP PLCsec.gov ↗
2026-02-1713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Bain Capital Life Sciences Opportunities IV, L.P.sec.gov ↗
2026-02-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Deep Track Capital, LPsec.gov ↗
2026-02-0513GSchedule 13G filed — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-01-308-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-01-128-K 7.01Regulation FD disclosuresec.gov ↗
2026-01-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-11-198-K 8.01Other eventssec.gov ↗
2025-11-188-K 8.01Other eventssec.gov ↗
2025-11-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by JANUS HENDERSON GROUP PLCsec.gov ↗
2025-11-108-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-208-K 8.01Other eventssec.gov ↗
2025-10-208-K 7.01Regulation FD disclosuresec.gov ↗
2025-09-028-K 8.01Other eventssec.gov ↗
2025-09-028-K 7.01Regulation FD disclosuresec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-09-02

Every row is a filed document, checked against its EDGAR index.